Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,259 | 61,925 | 27,256 | 32,441 | 54,036 |
| Marketable Securities | 182,735 | 172,153 | 164,561 | 166,074 | 156,227 |
| Receivables | N/A | 7 | 41 | 62 | 89 |
| TOTAL | $220,917 | $243,395 | $203,265 | $207,860 | $220,624 |
| Non-Current Assets | |||||
| PPE Net | 6,584 | 5,304 | 5,463 | 5,709 | 5,141 |
| Investments And Advances | 72,585 | 13,735 | 15,931 | 28,423 | 11,338 |
| Other Non-Current Assets | 23,728 | 23,402 | 28,718 | 26,294 | 29,448 |
| TOTAL | $102,897 | $42,441 | $50,112 | $60,426 | $45,927 |
| Total Assets | $323,814 | $285,836 | $253,377 | $268,286 | $266,551 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,503 | 1,860 | 1,057 | 2,061 | 1,904 |
| Accrued Expenses | 13,632 | 9,864 | 9,922 | 9,343 | 10,353 |
| TOTAL | $20,756 | $16,220 | $17,478 | $17,094 | $17,325 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,686 | 34,775 | 34,631 | 34,492 | 34,360 |
| Deferred Revenues | 333 | 333 | 333 | 333 | 333 |
| Other Non-Current Liabilities | 10,874 | 11,694 | 12,130 | 11,072 | 11,366 |
| TOTAL | $61,227 | $47,136 | $47,428 | $48,231 | $48,393 |
| Total Liabilities | $81,983 | $63,356 | $64,906 | $65,325 | $65,718 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,060 | 84,693 | 72,406 | 68,998 | 63,846 |
| Retained earnings | -410,429 | -376,759 | -348,580 | -331,328 | -306,153 |
| Other shareholders' equity | -582 | 237 | -841 | -252 | -85 |
| TOTAL | $241,831 | $222,480 | $188,471 | $202,961 | $200,833 |
| Total Liabilities And Equity | $323,814 | $285,836 | $253,377 | $268,286 | $266,551 |